KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares IssuedShort-Term Debt issuances
Ratios

Amneal Pharmaceuticals (AMRX) Receivables Refunds (2018 - 2019)

Historic Receivables Refunds for Amneal Pharmaceuticals (AMRX) over the last 2 years, with Q4 2019 value amounting to $13.7 million.

  • Amneal Pharmaceuticals' Receivables Refunds fell 5362.03% to $13.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $13.7 million, marking a year-over-year decrease of 5362.03%. This contributed to the annual value of $13.7 million for FY2019, which is 5362.03% down from last year.
  • As of Q4 2019, Amneal Pharmaceuticals' Receivables Refunds stood at $13.7 million, which was down 5362.03% from $29.6 million recorded in Q4 2018.
  • Amneal Pharmaceuticals' Receivables Refunds' 5-year high stood at $29.6 million during Q4 2018, with a 5-year trough of $13.7 million in Q4 2019.